Oncothyreon Inc (USA) (ONTY): Are Hedge Funds Right About This Stock?

Page 1 of 2

Oncothyreon Inc (USA) (NASDAQ:ONTY)Oncothyreon Inc (USA) (NASDAQ:ONTY) was in 9 hedge funds’ portfolio at the end of the fourth quarter of 2012. ONTY shareholders have witnessed a decrease in hedge fund interest recently. There were 10 hedge funds in our database with ONTY positions at the end of the previous quarter.

In today’s marketplace, there are a multitude of indicators market participants can use to track publicly traded companies. Some of the best are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best money managers can outpace the S&P 500 by a significant amount (see just how much).

Just as key, positive insider trading activity is another way to parse down the marketplace. There are plenty of reasons for an insider to sell shares of his or her company, but just one, very obvious reason why they would behave bullishly. Several empirical studies have demonstrated the impressive potential of this tactic if shareholders know where to look (learn more here).

Now, let’s take a peek at the key action surrounding Oncothyreon Inc (USA) (NASDAQ:ONTY).

How have hedgies been trading Oncothyreon Inc (USA) (NASDAQ:ONTY)?

In preparation for this year, a total of 9 of the hedge funds we track held long positions in this stock, a change of -10% from the previous quarter. With hedgies’ capital changing hands, there exists an “upper tier” of key hedge fund managers who were increasing their stakes considerably.

According to our comprehensive database, Andreas Halvorsen’s Viking Global had the biggest position in Oncothyreon Inc (USA) (NASDAQ:ONTY), worth close to $6.5 million, comprising less than 0.1%% of its total 13F portfolio. Sitting at the No. 2 spot is Phill Gross and Robert Atchinson of Adage Capital Management, with a $1.8 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Some other peers that are bullish include Kevin Kotler’s Broadfin Capital, D. E. Shaw’s D E Shaw and Jay Venkatesen’s Ayer Capital Management.

Since Oncothyreon Inc (USA) (NASDAQ:ONTY) has faced falling interest from hedge fund managers, it’s safe to say that there were a few money managers that decided to sell off their positions entirely last quarter. It’s worth mentioning that Jay Venkatesen’s Ayer Capital Management dumped the largest investment of the 450+ funds we key on, worth about $11.3 million in stock., and Samuel Isaly of OrbiMed Advisors was right behind this move, as the fund said goodbye to about $7.8 million worth. These moves are important to note, as total hedge fund interest fell by 1 funds last quarter.

What do corporate executives and insiders think about Oncothyreon Inc (USA) (NASDAQ:ONTY)?

Bullish insider trading is best served when the company in question has experienced transactions within the past 180 days. Over the last six-month time period, Oncothyreon Inc (USA) (NASDAQ:ONTY) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Oncothyreon Inc (USA) (NASDAQ:ONTY). These stocks are Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Cell Therapeutics Inc (NASDAQ:CTIC), NeoStem Inc (NYSEAMEX:NBS), and Biota Pharmaceuticals Inc (NASDAQ:BOTA). This group of stocks are in the biotechnology industry and their market caps are closest to ONTY’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

The 20 Biggest Contracts in MLB History

The 7 Worst Blown Calls in Sports History

7 Free Ways to Advertise Your Business Online

The 18 Best R&B Songs of the 90’s

The 10 Most Dangerous States to be a Cop

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!